IXCELLENCE NETWORK CENTERS OF EXCELLENCE FOR HCP EDUCATION
LIVE

Serial Number

79398735

Owner

IPSEN BIOPHARM LIMITED

Attorney

Ben Natter

Filing Date

Jan 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

IXCELLENCE NETWORK CENTERS OF EXCELLENCE FOR HCP EDUCATION Trademark

Serial Number: 79398735 • Registration: 7726455

IXCELLENCE NETWORK CENTERS OF EXCELLENCE FOR HCP EDUCATION is a trademark filed by IPSEN BIOPHARM LIMITED on January 22, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

IPSEN BIOPHARM LIMITED (68 trademarks)

ASH ROAD
WREXHAM LL13 9UF , GB

Entity Type: 03

Trademark Details

Filing Date

January 22, 2024

Registration Date

March 18, 2025

Published for Opposition

January 28, 2025

Goods & Services

Online social networking services in the field of botulinum toxin.

Providing medical information to healthcare professionals, including medical information provided via a website

Downloadable electronic publications in the nature of podcasts in the field of botulinum toxin

Education and training services for healthcare professionals, namely, conducting providing live and on-line classes, colloquiums, conferences, congresses, seminars, symposiums and workshops in the field of botulinum toxin; arranging and conducting of colloquiums, conferences, congresses, seminars, symposiums in the field of botulinum toxin; providing online non-downloadable publications in the nature of podcasts, articles and brochures in the field of botulinum toxin

Printed matter, namely, hand-outs, brochures, and printed teaching materials all in the field of botulinum toxin

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2026 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 26, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 18, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 1, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 30, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 19, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 9, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 9, 2025 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2024 CRFA
ASSIGNED TO LIE
Dec 18, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 18, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 17, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 17, 2024 GNSL
SUSPENSION LETTER WRITTEN
Oct 17, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 21, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 31, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 16, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Aug 9, 2024 NREP
APPLICATION FILING RECEIPT MAILED
Jul 3, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2024 REPR